YL Biologics Overview
- Year Founded
-
2014
- Status
-
Private
- Latest Deal Type
-
Joint Venture
- Financing Rounds
-
1
YL Biologics General Information
Description
Provider of clinical development services. The company is engaged in providing in conducting clinical development of certain Biosimilars such as regulatory filings and obtaining marketing authorizations in Japan.
Contact Information
Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Corporate Office
- Tokyo
- Japan
Primary Industry
Biotechnology
Corporate Office
- Tokyo
- Japan
YL Biologics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
YL Biologics Executive Team (1)
| Name | Title | Board Seat |
|---|---|---|
| Donghyun Kim Ph.D | General Manager |
YL Biologics Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
YL Biologics FAQs
-
When was YL Biologics founded?
YL Biologics was founded in 2014.
-
Where is YL Biologics headquartered?
YL Biologics is headquartered in Tokyo, Japan.
-
What industry is YL Biologics in?
YL Biologics’s primary industry is Biotechnology.
-
Is YL Biologics a private or public company?
YL Biologics is a Private company.
-
What is YL Biologics’s current revenue?
The current revenue for YL Biologics is .
-
Who are YL Biologics’s investors?
Lupin and Yoshindo have invested in YL Biologics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
